pharmafocuseurope.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Pharma Focus Europe | Latest Pharmaceutical Industry News and |
| Description | LATEST NEWSRead Pharma Focus Europe, published by Ochre digi media, leading pharma digital magazine serving the implementation needs of key executives from the worlds leading pharmaceutical |
| Keywords | Pharma Focus Europe, pharma magazine in Europe, pharmaceutical europe magazine |
Server Information
| WebSite | |
| Host IP | 57.128.128.108 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
pharmafocuseurope.com Valuation
|
US$910
Last updated: 2023-05-19 12:30:13
pharmafocuseurope.com has Semrush global rank of 0. pharmafocuseurope.com has an estimated worth of US$ 910, based on its estimated Ads revenue. pharmafocuseurope.com receives approximately 105 unique visitors each day. Its web server is located in United States, with IP address 57.128.128.108. According to SiteAdvisor, pharmafocuseurope.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$910 |
| Daily Ads Revenue | US$0 |
| Monthly Ads Revenue | US$25 |
| Yearly Ads Revenue | US$302 |
| Daily Unique Visitors | 7 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| pharmafocuseurope.com. | A | 3600 | IP: 57.128.128.108 |
| pharmafocuseurope.com. | NS | 21600 | NS Record: ns-cloud-d3.googledomains.com. |
| pharmafocuseurope.com. | NS | 21600 | NS Record: ns-cloud-d1.googledomains.com. |
| pharmafocuseurope.com. | NS | 21600 | NS Record: ns-cloud-d2.googledomains.com. |
| pharmafocuseurope.com. | NS | 21600 | NS Record: ns-cloud-d4.googledomains.com. |
| pharmafocuseurope.com. | MX | 3600 | MX Record: 1 aspmx.l.google.com. |
| pharmafocuseurope.com. | MX | 3600 | MX Record: 10 alt4.aspmx.l.google.com. |
| pharmafocuseurope.com. | MX | 3600 | MX Record: 5 alt1.aspmx.l.google.com. |
| pharmafocuseurope.com. | MX | 3600 | MX Record: 10 alt3.aspmx.l.google.com. |
| pharmafocuseurope.com. | MX | 3600 | MX Record: 5 alt2.aspmx.l.google.com. |
| pharmafocuseurope.com. | TXT | 3600 | TXT Record: google-site-verification=w57vZRgsYs1MErEfWY2aragQvXGxpR-QyBpau6z8kqk |
| pharmafocuseurope.com. | TXT | 3600 | TXT Record: google-site-verification=MmEsVJYohhgOiNpAiCD_g98oaJdBhbh0G5Rr4BiUd0k |
HtmlToTextCheckTime:2023-05-19 12:30:13
| HOME (current) EDITORIAL SECTION Strategy Research & Development Clinical Trials Manufacturing Information Technology Expert Talk GET PUBLISHED MAGAZINE Previous Issues e-Book Archives Foreword Author Guidelines Advisory Board Editorial Calendar --> --> KNOWLEDGE BANK Articles Techno Trends Projects Research Insights Book Shelf INDUSTRY UPDATE News Press Releases Events ADVERTISE Advertorials Print Online Target Market Target Audience Tech Specs Mediapack Terms --> --> WEBINARS SUBSCRIBE E-NEWSLETTER E-Newsletter Subscription MAGAZINE Magazine Subscription Model-Informed Drug Development (MIDD) - EMA’s Advancement HYBRID EXOSOMES: A Novel Platform for Cancer Therapy Effective Biomarkers in Uncovering Novel Target Molecules for a Drug C-MET Receptor Tyrosine Kinase: A Potential Biomarker for Cancer Therapeutics New Pharmacological Targets and Biomarkers for the Treatment of Tuberculosis (TB) BENEFITS AND CHALLENGES OF USING WEARABLES IN CLINICAL TRIALS Decentralising |
HTTP Headers
HTTP/1.1 301 Moved Permanently Connection: Keep-Alive Date: Fri, 07 Oct 2022 08:25:06 GMT Location: https://www.pharmafocuseurope.com/ Access-Control-Allow-Origin: * X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff HTTP/2 200 cache-control: no-cache, private content-type: text/html; charset=UTF-8 set-cookie: XSRF-TOKEN=eyJpdiI6ImVsaFNQclBqdktmVnNLNnZNQjdvbXc9PSIsInZhbHVlIjoiR0JRbkhJWVFuN25mZHUwNDJJclBRV2FvY2hrS2xhRThvSzRlXC83ckhHWGYxY3F1YzlmZldcL0pMWEExSVZLYlh4IiwibWFjIjoiYTkzZTQ3NDExYzk3ZWE2NGU3NDk2ODExYzkzYzEwNDcwNDE2M2UwN2MxOTA2MzMzZWNlNGQ2Y2MyNGVkZjdmYyJ9; expires=Fri, 07-Oct-2022 10:25:06 GMT; Max-Age=7200; path=/; secure set-cookie: pharmafocuseurope_session=eyJpdiI6IkNiWmRqZGpXUGNIRTNpUENxZFFBR3c9PSIsInZhbHVlIjoieXN6S0ExMjUyVzJQNFhLTk5DOE84ZHpvYmF0WWtnMTBYUWpcL2VhNnUxWGY5d0FRNmVEUFdjYTE2OG1aYXk0emQiLCJtYWMiOiIyYWYzZTE3Yzg2ZWRjNDUwZTBiODRkMmM4ZWVkNjFiM2UzZjI4OTM4MmM4NjFiZTQ4ODg4ZTFlY2E4NjMwODdmIn0%3D; expires=Fri, 07-Oct-2022 10:25:06 GMT; Max-Age=7200; path=/; httponly; secure date: Fri, 07 Oct 2022 08:25:06 GMT access-control-allow-origin: * x-xss-protection: 1; mode=block x-content-type-options: nosniff alt-svc: quic=":443"; ma=2592000; v="43,46", h3-Q043=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-25=":443"; ma=2592000, h3-27=":443"; ma=2592000 |
pharmafocuseurope.com Whois Information
Domain Name: PHARMAFOCUSEUROPE.COM Registry Domain ID: 2678990430_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.google.com Registrar URL: http://domains.google.com Updated Date: 2022-10-06T06:38:55Z Creation Date: 2022-03-03T10:43:39Z Registry Expiry Date: 2023-03-03T10:43:39Z Registrar: Google LLC Registrar IANA ID: 895 Registrar Abuse Contact Email: registrar-abuse@google.com Registrar Abuse Contact Phone: +1.8772376466 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-CLOUD-D1.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-D2.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-D3.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-D4.GOOGLEDOMAINS.COM DNSSEC: signedDelegation DNSSEC DS Data: 51194 8 2 F72F9D757A568DA7E1139BB59435ECD874DF89E2EF601D4822CF449FB1185223 >>> Last update of whois database: 2022-10-07T08:21:45Z <<< |